Risk factors for pathologically confirmed benign breast disease

F. Parazzini, C. La Vecchia, S. Franceschi, A. Decarli, G. Gallus, M. Regallo, A. Liberati, G. Tognoni

Research output: Contribution to journalArticle

Abstract

Between November 1981 and March 1983, data were collected to evaluate risk factors for benign breast lesions in a case-control study based on 288 women with histologically proven benign breast disease, admitted for biopsy to the Tumor Institute of Milan, and 285 age-matched controls. Questions were asked about menstrual and reproductive characteristics, marital status, education, history of various diseases, and lifetime use of oral contraceptives and other hormonal treatments. Nulliparity or low parity, late age at first birth, and late menopause were associated with an increased risk of benign breast disease. The elevated risk associated with late age at first birth was not accounted for by parity. Early age at menarche was associated with an increased risk, but the estimate was not statistically significant. The data do not suggest that the use of oral contraceptives or other female hormones (such as estrogen replacement therapy) is related to the risk of benign breast disease. Risk was apparently lower, however, among current and long-term oral contraceptive users. There was no evidence of a trend with reference to body mass index. The present data indicate a substantial agreement between the risk factors for (pathologically confirmed) benign and malignant breast disease, not only directly, by showing a relationship with parity, age at first birth, and age at menopause, but also indirectly, by failing to produce evidence that greater weight or the use of oral contraceptives has a protective effect.

Original languageEnglish
Pages (from-to)115-122
Number of pages8
JournalAmerican Journal of Epidemiology
Volume120
Issue number1
Publication statusPublished - 1984

Fingerprint

Breast Diseases
Parity
Birth Order
Oral Contraceptives
Menopause
Contraceptives, Oral, Hormonal
Menarche
Estrogen Replacement Therapy
Marital Status
Case-Control Studies
Breast
Body Mass Index
Hormones
Biopsy
Education
Weights and Measures
Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Geriatrics and Gerontology

Cite this

Parazzini, F., La Vecchia, C., Franceschi, S., Decarli, A., Gallus, G., Regallo, M., ... Tognoni, G. (1984). Risk factors for pathologically confirmed benign breast disease. American Journal of Epidemiology, 120(1), 115-122.

Risk factors for pathologically confirmed benign breast disease. / Parazzini, F.; La Vecchia, C.; Franceschi, S.; Decarli, A.; Gallus, G.; Regallo, M.; Liberati, A.; Tognoni, G.

In: American Journal of Epidemiology, Vol. 120, No. 1, 1984, p. 115-122.

Research output: Contribution to journalArticle

Parazzini, F, La Vecchia, C, Franceschi, S, Decarli, A, Gallus, G, Regallo, M, Liberati, A & Tognoni, G 1984, 'Risk factors for pathologically confirmed benign breast disease', American Journal of Epidemiology, vol. 120, no. 1, pp. 115-122.
Parazzini F, La Vecchia C, Franceschi S, Decarli A, Gallus G, Regallo M et al. Risk factors for pathologically confirmed benign breast disease. American Journal of Epidemiology. 1984;120(1):115-122.
Parazzini, F. ; La Vecchia, C. ; Franceschi, S. ; Decarli, A. ; Gallus, G. ; Regallo, M. ; Liberati, A. ; Tognoni, G. / Risk factors for pathologically confirmed benign breast disease. In: American Journal of Epidemiology. 1984 ; Vol. 120, No. 1. pp. 115-122.
@article{ec91e5c97224416d985f29d0a3a765ea,
title = "Risk factors for pathologically confirmed benign breast disease",
abstract = "Between November 1981 and March 1983, data were collected to evaluate risk factors for benign breast lesions in a case-control study based on 288 women with histologically proven benign breast disease, admitted for biopsy to the Tumor Institute of Milan, and 285 age-matched controls. Questions were asked about menstrual and reproductive characteristics, marital status, education, history of various diseases, and lifetime use of oral contraceptives and other hormonal treatments. Nulliparity or low parity, late age at first birth, and late menopause were associated with an increased risk of benign breast disease. The elevated risk associated with late age at first birth was not accounted for by parity. Early age at menarche was associated with an increased risk, but the estimate was not statistically significant. The data do not suggest that the use of oral contraceptives or other female hormones (such as estrogen replacement therapy) is related to the risk of benign breast disease. Risk was apparently lower, however, among current and long-term oral contraceptive users. There was no evidence of a trend with reference to body mass index. The present data indicate a substantial agreement between the risk factors for (pathologically confirmed) benign and malignant breast disease, not only directly, by showing a relationship with parity, age at first birth, and age at menopause, but also indirectly, by failing to produce evidence that greater weight or the use of oral contraceptives has a protective effect.",
author = "F. Parazzini and {La Vecchia}, C. and S. Franceschi and A. Decarli and G. Gallus and M. Regallo and A. Liberati and G. Tognoni",
year = "1984",
language = "English",
volume = "120",
pages = "115--122",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Risk factors for pathologically confirmed benign breast disease

AU - Parazzini, F.

AU - La Vecchia, C.

AU - Franceschi, S.

AU - Decarli, A.

AU - Gallus, G.

AU - Regallo, M.

AU - Liberati, A.

AU - Tognoni, G.

PY - 1984

Y1 - 1984

N2 - Between November 1981 and March 1983, data were collected to evaluate risk factors for benign breast lesions in a case-control study based on 288 women with histologically proven benign breast disease, admitted for biopsy to the Tumor Institute of Milan, and 285 age-matched controls. Questions were asked about menstrual and reproductive characteristics, marital status, education, history of various diseases, and lifetime use of oral contraceptives and other hormonal treatments. Nulliparity or low parity, late age at first birth, and late menopause were associated with an increased risk of benign breast disease. The elevated risk associated with late age at first birth was not accounted for by parity. Early age at menarche was associated with an increased risk, but the estimate was not statistically significant. The data do not suggest that the use of oral contraceptives or other female hormones (such as estrogen replacement therapy) is related to the risk of benign breast disease. Risk was apparently lower, however, among current and long-term oral contraceptive users. There was no evidence of a trend with reference to body mass index. The present data indicate a substantial agreement between the risk factors for (pathologically confirmed) benign and malignant breast disease, not only directly, by showing a relationship with parity, age at first birth, and age at menopause, but also indirectly, by failing to produce evidence that greater weight or the use of oral contraceptives has a protective effect.

AB - Between November 1981 and March 1983, data were collected to evaluate risk factors for benign breast lesions in a case-control study based on 288 women with histologically proven benign breast disease, admitted for biopsy to the Tumor Institute of Milan, and 285 age-matched controls. Questions were asked about menstrual and reproductive characteristics, marital status, education, history of various diseases, and lifetime use of oral contraceptives and other hormonal treatments. Nulliparity or low parity, late age at first birth, and late menopause were associated with an increased risk of benign breast disease. The elevated risk associated with late age at first birth was not accounted for by parity. Early age at menarche was associated with an increased risk, but the estimate was not statistically significant. The data do not suggest that the use of oral contraceptives or other female hormones (such as estrogen replacement therapy) is related to the risk of benign breast disease. Risk was apparently lower, however, among current and long-term oral contraceptive users. There was no evidence of a trend with reference to body mass index. The present data indicate a substantial agreement between the risk factors for (pathologically confirmed) benign and malignant breast disease, not only directly, by showing a relationship with parity, age at first birth, and age at menopause, but also indirectly, by failing to produce evidence that greater weight or the use of oral contraceptives has a protective effect.

UR - http://www.scopus.com/inward/record.url?scp=0021243194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021243194&partnerID=8YFLogxK

M3 - Article

C2 - 6741913

AN - SCOPUS:0021243194

VL - 120

SP - 115

EP - 122

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 1

ER -